SLC13A5 and epilepsy: These findings suggest SLC13A5 citrate transporter disorder is a developmental and epileptic encephalopathy (DEE) (Stafstrom and Kossoff, 2016; Scheffer and Liao, 2020), in which biological processes caused by the disorder—both related to and independent of seizures and epilepsy—impact development, and the interplay of both might determine cognitive and developmental outcomes.